73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB184
DOI: 10.1016/j.jaad.2026.04.752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Federica Li Pomi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pomi, F. L., Vaccaro, M., & Borgia, F. (2026). 73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study. Journal of the American Academy of Dermatology, 95(1), AB184. https://doi.org/10.1016/j.jaad.2026.04.752
Vancouver
Pomi FL, Vaccaro M, Borgia F. 73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study. Journal of the American Academy of Dermatology. 2026;95(1):AB184. doi:10.1016/j.jaad.2026.04.752
BibTeX
@article{Pomi2026,
author = {Pomi, Federica Li and Vaccaro, Mario and Borgia, Francesco},
title = {73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB184},
doi = {10.1016/j.jaad.2026.04.752}
}
EUVIMED